(Q45356680)

13 December 2017

Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients (English)

1 reference

13 December 2017

0 references

F Bernal

1

1 reference

13 December 2017

B Elias

series ordinal

2

1 reference

13 December 2017

H P Hartung

series ordinal

3

1 reference

13 December 2017

B C Kieseier

series ordinal

4

1 reference

13 December 2017

21 April 2009

1 reference

Multiple Sclerosis Journal

13 December 2017

1 reference

13 December 2017

15

1 reference

13 December 2017

6

1 reference

13 December 2017

721-727

1 reference

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

13 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Metalloproteinases in biology and pathology of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Metalloproteinases: mediators of pathology and regeneration in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Statistical analysis of real-time PCR data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Controlling the familywise error rate in functional neuroimaging: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509102920

21 January 2018

Identifiers

DOI

10.1177/1352458509102920

1 reference

13 December 2017

1 reference